Trial Profile
Safety and Efficacy study of CRD-102 in patients with Heart Failure with Preserved Ejection Fraction
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs CRD 102 (Primary)
- Indications Heart failure
- Focus Adverse reactions; Therapeutic Use
- Acronyms CRD-102 HFPEF
- Sponsors Cardiora
- 17 Nov 2017 Status changed from not yet recruiting to recruiting.
- 18 Jun 2016 New trial record